Your browser doesn't support javascript.
loading
Prognostic Value of Serum Apolipoprotein B to Apolipoprotein A-I Ratio in Hepatocellular Carcinoma Patients Treated with Transcatheter Arterial Chemoembolization: A Propensity Score-Matched Analysis.
Liu, Meng-Meng; Chen, Zhan-Hong; Zhao, Li-Yun; Zhao, Jing-Yuan; Rong, Dai-Lin; Ma, Xiao-Kun; Ruan, Dan-Yun; Lin, Jin-Xiang; Qi, Jing-Jing; Hu, Pei-Shan; Wen, Jing-Yun; Chen, Jie; Lin, Qu; Wu, Xiang-Yuan; Wei, Li; Dong, Min.
Afiliación
  • Liu MM; Department of Medical Oncology and Guangdong Key Laboratory of Liver Disease, Third Affiliated Hospital of Sun Yat-Sen University, Guangzhou, China.
  • Chen ZH; Department of Medical Oncology and Guangdong Key Laboratory of Liver Disease, Third Affiliated Hospital of Sun Yat-Sen University, Guangzhou, China.
  • Zhao LY; Department of Medical Oncology of Sun Yat-Sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, China.
  • Zhao JY; Department of Medical Oncology and Guangdong Key Laboratory of Liver Disease, Third Affiliated Hospital of Sun Yat-Sen University, Guangzhou, China.
  • Rong DL; Department of Medical Oncology and Guangdong Key Laboratory of Liver Disease, Third Affiliated Hospital of Sun Yat-Sen University, Guangzhou, China.
  • Ma XK; Department of Radiology and Guangdong Key Laboratory of Liver Disease, the Third Affiliated Hospital of Sun Yat-Sen University, Guangzhou, China.
  • Ruan DY; Department of Medical Oncology and Guangdong Key Laboratory of Liver Disease, Third Affiliated Hospital of Sun Yat-Sen University, Guangzhou, China.
  • Lin JX; Department of Medical Oncology and Guangdong Key Laboratory of Liver Disease, Third Affiliated Hospital of Sun Yat-Sen University, Guangzhou, China.
  • Qi JJ; Department of Medical Oncology and Guangdong Key Laboratory of Liver Disease, Third Affiliated Hospital of Sun Yat-Sen University, Guangzhou, China.
  • Hu PS; Department of Medical Oncology of Sun Yat-Sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, China.
  • Wen JY; Department of Medical Oncology of Sun Yat-Sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, China.
  • Chen J; Department of Medical Oncology and Guangdong Key Laboratory of Liver Disease, Third Affiliated Hospital of Sun Yat-Sen University, Guangzhou, China.
  • Lin Q; Department of Medical Oncology and Guangdong Key Laboratory of Liver Disease, Third Affiliated Hospital of Sun Yat-Sen University, Guangzhou, China.
  • Wu XY; Department of Medical Oncology and Guangdong Key Laboratory of Liver Disease, Third Affiliated Hospital of Sun Yat-Sen University, Guangzhou, China.
  • Wei L; Department of Medical Oncology and Guangdong Key Laboratory of Liver Disease, Third Affiliated Hospital of Sun Yat-Sen University, Guangzhou, China.
  • Dong M; Department of Medical Oncology and Guangdong Key Laboratory of Liver Disease, Third Affiliated Hospital of Sun Yat-Sen University, Guangzhou, China.
Oncol Res Treat ; 44(9): 450-468, 2021.
Article en En | MEDLINE | ID: mdl-34380137
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Quimioembolización Terapéutica / Carcinoma Hepatocelular / Neoplasias Hepáticas Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Oncol Res Treat Año: 2021 Tipo del documento: Article País de afiliación: China Pais de publicación: Suiza
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Quimioembolización Terapéutica / Carcinoma Hepatocelular / Neoplasias Hepáticas Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Oncol Res Treat Año: 2021 Tipo del documento: Article País de afiliación: China Pais de publicación: Suiza